Reference

KPV acetate

Status · October 2026

Under an interim HHS enforcement-discretion policy filed with the Federal Register on October 28, 2026, HHS has said it will not prioritize enforcement against State-licensed pharmacies, Federal facilities and licensed physicians that compound KPV (acetate) for a patient-specific prescription, for the routes below and under the policy’s other conditions. This is not FDA approval. Compounded drugs are not FDA-approved, and HHS can change or withdraw the policy.

Read the HHS policy (PDF)

HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (PDF, hhs.gov)

Covered form
acetateOther forms are not covered.
Covered routes
  • Oral
  • Topical
Ingredients
Single ingredient only. Blends aren’t covered.
Needs
A prescription written for you
Note
Oral forms are covered only when the compounder documents adequate oral bioavailability in humans (condition 8 of the policy).
In Ondial
KPV is saved as acetate, and only the covered routes above can be picked. Dose and strength are copied from your label as you see them; Ondial never suggests either.

Ask your prescriber

  • What should I do if I miss a dose?
  • Which side effects mean I should call you?
  • How should I store it, and for how long?
  • When should I stop taking it?

Ondial is a tracking tool, not medical advice. Not affiliated with HHS, the FDA or any pharmacy.